Cargando…

Comparison of active treatments for impaired glucose regulation: a Salford Royal Foundation Trust and Hitachi collaboration (CATFISH): study protocol for a randomized controlled trial

BACKGROUND: Diabetes is highly prevalent and contributes to significant morbidity and mortality worldwide. Behaviour change interventions that target health and lifestyle factors associated with the onset of diabetes can delay progression to diabetes, but many approaches rely on intensive one-to-one...

Descripción completa

Detalles Bibliográficos
Autores principales: Coventry, Peter A., Bower, Peter, Blakemore, Amy, Baker, Liz, Hann, Mark, Paisley, Angela, Renwick, Charlotte, Li, Jinshuo, Ugajin, Atushi, Gibson, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5000461/
https://www.ncbi.nlm.nih.gov/pubmed/27561822
http://dx.doi.org/10.1186/s13063-016-1519-6
_version_ 1782450289012375552
author Coventry, Peter A.
Bower, Peter
Blakemore, Amy
Baker, Liz
Hann, Mark
Paisley, Angela
Renwick, Charlotte
Li, Jinshuo
Ugajin, Atushi
Gibson, Martin
author_facet Coventry, Peter A.
Bower, Peter
Blakemore, Amy
Baker, Liz
Hann, Mark
Paisley, Angela
Renwick, Charlotte
Li, Jinshuo
Ugajin, Atushi
Gibson, Martin
author_sort Coventry, Peter A.
collection PubMed
description BACKGROUND: Diabetes is highly prevalent and contributes to significant morbidity and mortality worldwide. Behaviour change interventions that target health and lifestyle factors associated with the onset of diabetes can delay progression to diabetes, but many approaches rely on intensive one-to-one contact by specialists. Health coaching is an approach based on motivational interviewing that can potentially deliver behaviour change interventions by non-specialists at a larger scale. This trial protocol describes a randomized controlled trial (CATFISH) that tests whether a web-enhanced telephone health coaching intervention (IGR3) is more acceptable and efficient than a telephone-only health coaching intervention (IGR2) for people with prediabetes (impaired glucose regulation). METHODS: CATFISH is a two-parallel group, single-centre individually randomized controlled trial. Eligible participants are patients aged ≥18 years with impaired glucose regulation (HbA1c concentration between 42 and 47 mmol/mol), have access to a telephone and home internet and have been referred to an existing telephone health coaching service at Salford Royal NHS Foundation Trust, Salford, UK. Participants who give written informed consent will be randomized remotely (via a clinical trials unit) to either the existing pathway (IGR2) or the new web-enhanced pathway (IGR3) for 9 months. The primary outcome measure is patient acceptability at 9 months, determined using the Client Satisfaction Questionnaire. Secondary outcome measures at 9 months are: cost of delivery of IGR2 and IGR3, mental health, quality of life, patient activation, self-management, weight (kg), HbA1c concentration, and body mass index. All outcome measures will be analyzed on an intention-to-treat basis. A qualitative process evaluation will explore the experiences of participants and providers with a focus on understanding usability of interventions, mechanisms of behaviour change, and impact of context on delivery and user acceptability. Qualitative data will be analyzed using Framework. DISCUSSION: The CATFISH trial will provide a pragmatic assessment of whether a web-based information technology platform can enhance acceptability of a telephone health coaching intervention for people with prediabetes. The data will prove critical in understanding the role of web applications to improve engagement with evidence-based approaches to preventing diabetes. TRIAL REGISTRATION: ISRCTN16534814. Registered on 7 February 2016. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13063-016-1519-6) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5000461
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-50004612016-08-27 Comparison of active treatments for impaired glucose regulation: a Salford Royal Foundation Trust and Hitachi collaboration (CATFISH): study protocol for a randomized controlled trial Coventry, Peter A. Bower, Peter Blakemore, Amy Baker, Liz Hann, Mark Paisley, Angela Renwick, Charlotte Li, Jinshuo Ugajin, Atushi Gibson, Martin Trials Study Protocol BACKGROUND: Diabetes is highly prevalent and contributes to significant morbidity and mortality worldwide. Behaviour change interventions that target health and lifestyle factors associated with the onset of diabetes can delay progression to diabetes, but many approaches rely on intensive one-to-one contact by specialists. Health coaching is an approach based on motivational interviewing that can potentially deliver behaviour change interventions by non-specialists at a larger scale. This trial protocol describes a randomized controlled trial (CATFISH) that tests whether a web-enhanced telephone health coaching intervention (IGR3) is more acceptable and efficient than a telephone-only health coaching intervention (IGR2) for people with prediabetes (impaired glucose regulation). METHODS: CATFISH is a two-parallel group, single-centre individually randomized controlled trial. Eligible participants are patients aged ≥18 years with impaired glucose regulation (HbA1c concentration between 42 and 47 mmol/mol), have access to a telephone and home internet and have been referred to an existing telephone health coaching service at Salford Royal NHS Foundation Trust, Salford, UK. Participants who give written informed consent will be randomized remotely (via a clinical trials unit) to either the existing pathway (IGR2) or the new web-enhanced pathway (IGR3) for 9 months. The primary outcome measure is patient acceptability at 9 months, determined using the Client Satisfaction Questionnaire. Secondary outcome measures at 9 months are: cost of delivery of IGR2 and IGR3, mental health, quality of life, patient activation, self-management, weight (kg), HbA1c concentration, and body mass index. All outcome measures will be analyzed on an intention-to-treat basis. A qualitative process evaluation will explore the experiences of participants and providers with a focus on understanding usability of interventions, mechanisms of behaviour change, and impact of context on delivery and user acceptability. Qualitative data will be analyzed using Framework. DISCUSSION: The CATFISH trial will provide a pragmatic assessment of whether a web-based information technology platform can enhance acceptability of a telephone health coaching intervention for people with prediabetes. The data will prove critical in understanding the role of web applications to improve engagement with evidence-based approaches to preventing diabetes. TRIAL REGISTRATION: ISRCTN16534814. Registered on 7 February 2016. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13063-016-1519-6) contains supplementary material, which is available to authorized users. BioMed Central 2016-08-26 /pmc/articles/PMC5000461/ /pubmed/27561822 http://dx.doi.org/10.1186/s13063-016-1519-6 Text en © Coventry et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Study Protocol
Coventry, Peter A.
Bower, Peter
Blakemore, Amy
Baker, Liz
Hann, Mark
Paisley, Angela
Renwick, Charlotte
Li, Jinshuo
Ugajin, Atushi
Gibson, Martin
Comparison of active treatments for impaired glucose regulation: a Salford Royal Foundation Trust and Hitachi collaboration (CATFISH): study protocol for a randomized controlled trial
title Comparison of active treatments for impaired glucose regulation: a Salford Royal Foundation Trust and Hitachi collaboration (CATFISH): study protocol for a randomized controlled trial
title_full Comparison of active treatments for impaired glucose regulation: a Salford Royal Foundation Trust and Hitachi collaboration (CATFISH): study protocol for a randomized controlled trial
title_fullStr Comparison of active treatments for impaired glucose regulation: a Salford Royal Foundation Trust and Hitachi collaboration (CATFISH): study protocol for a randomized controlled trial
title_full_unstemmed Comparison of active treatments for impaired glucose regulation: a Salford Royal Foundation Trust and Hitachi collaboration (CATFISH): study protocol for a randomized controlled trial
title_short Comparison of active treatments for impaired glucose regulation: a Salford Royal Foundation Trust and Hitachi collaboration (CATFISH): study protocol for a randomized controlled trial
title_sort comparison of active treatments for impaired glucose regulation: a salford royal foundation trust and hitachi collaboration (catfish): study protocol for a randomized controlled trial
topic Study Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5000461/
https://www.ncbi.nlm.nih.gov/pubmed/27561822
http://dx.doi.org/10.1186/s13063-016-1519-6
work_keys_str_mv AT coventrypetera comparisonofactivetreatmentsforimpairedglucoseregulationasalfordroyalfoundationtrustandhitachicollaborationcatfishstudyprotocolforarandomizedcontrolledtrial
AT bowerpeter comparisonofactivetreatmentsforimpairedglucoseregulationasalfordroyalfoundationtrustandhitachicollaborationcatfishstudyprotocolforarandomizedcontrolledtrial
AT blakemoreamy comparisonofactivetreatmentsforimpairedglucoseregulationasalfordroyalfoundationtrustandhitachicollaborationcatfishstudyprotocolforarandomizedcontrolledtrial
AT bakerliz comparisonofactivetreatmentsforimpairedglucoseregulationasalfordroyalfoundationtrustandhitachicollaborationcatfishstudyprotocolforarandomizedcontrolledtrial
AT hannmark comparisonofactivetreatmentsforimpairedglucoseregulationasalfordroyalfoundationtrustandhitachicollaborationcatfishstudyprotocolforarandomizedcontrolledtrial
AT paisleyangela comparisonofactivetreatmentsforimpairedglucoseregulationasalfordroyalfoundationtrustandhitachicollaborationcatfishstudyprotocolforarandomizedcontrolledtrial
AT renwickcharlotte comparisonofactivetreatmentsforimpairedglucoseregulationasalfordroyalfoundationtrustandhitachicollaborationcatfishstudyprotocolforarandomizedcontrolledtrial
AT lijinshuo comparisonofactivetreatmentsforimpairedglucoseregulationasalfordroyalfoundationtrustandhitachicollaborationcatfishstudyprotocolforarandomizedcontrolledtrial
AT ugajinatushi comparisonofactivetreatmentsforimpairedglucoseregulationasalfordroyalfoundationtrustandhitachicollaborationcatfishstudyprotocolforarandomizedcontrolledtrial
AT gibsonmartin comparisonofactivetreatmentsforimpairedglucoseregulationasalfordroyalfoundationtrustandhitachicollaborationcatfishstudyprotocolforarandomizedcontrolledtrial